• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BLOCK DRUG CO., INC. COREGA TABS BIO FORMULA; DENTURE CLEANSER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BLOCK DRUG CO., INC. COREGA TABS BIO FORMULA; DENTURE CLEANSER Back to Search Results
Device Problem Human Factors Issue (2948)
Patient Problems Injury (2348); Foreign Body In Patient (2687)
Event Date 06/15/2017
Event Type  Injury  
Manufacturer Narrative
This report is associated with argus (b)(4), corega tabs bio formula.Corega tabs bio formula is marketed as polident in the us.
 
Event Description
Accidental exposure [accidental device ingestion by a child].Case description: this case was reported by a consumer via call center representative and described the occurrence of accidental device ingestion by a child in a (b)(6) female patient who received double salt denture cleanser 10791-02-001 (corega tabs bio formula) tablet for drug use for unknown indication.On an unknown date, the patient started corega tabs bio formula.On (b)(6) 2017, an unknown time after starting corega tabs bio formula, the patient experienced accidental device ingestion by a child (serious criteria gsk medically significant).On an unknown date, the outcome of the accidental device ingestion by a child was recovered/resolved.The reporter considered the accidental device ingestion by a child to be related to corega tabs bio formula.Additional information: case reported to pv through call centre representative.(b)(6) female drank some liquid with corega oxigeno bioactivo (accidental exposure) on (b)(6) 2017.She was advised to go to hospital emergency room for examination.On 19/06/2017 pv contacted for fu information.The patient did not present any adverse event but as precaution, they went to hospital emergency room for examination.At medical examination, the patient did not present any event so no treatment was prescribed.At reporting date no events had appeared.The case is closed.
 
Manufacturer Narrative
This report is associated with argus case (b)(4), corega tabs bio formula.Corega tabs bio formula is marketed as polident in the us.
 
Event Description
Case description: this case was reported by a consumer via call center representative and described the occurrence of accidental device ingestion by a child in a (b)(6) female patient who received double salt denture cleanser 10791-02-001 (corega tabs bio formula) tablet for drug use for unknown indication.On an unknown date, the patient started corega tabs bio formula.On (b)(6) 2017, an unknown time after starting corega tabs bio formula, the patient experienced accidental device ingestion by a child (serious criteria gsk medically significant).On an unknown date, the outcome of the accidental device ingestion by a child was recovered/resolved.The reporter considered the accidental device ingestion by a child to be related to corega tabs bio formula.Additional information case reported to pv through call centre representative.(b)(6) female drank some liquid with corega oxigeno bioactivo (accidental exposure) on (b)(6) 2017.She was advised to go to hospital emergency room for examination.On 19/06/2017 pv contacted for fu information.The patient did not present any adverse event but as precaution, they went to hospital emergency room for examination.At medical examination, the patient did not present any event so no treatment was prescribed.At reporting date no events had appeared.The case is closed.Follow up information received 06 july 2017 the event occurred on (b)(6) 2017 and she went to emergency room for examination on (b)(6) 2017.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COREGA TABS BIO FORMULA
Type of Device
DENTURE CLEANSER
Manufacturer (Section D)
BLOCK DRUG CO., INC.
2149 harbor avenue
memphis TN 38113
Manufacturer (Section G)
GSK
Manufacturer Contact
po box 13398
research triangle park, NC 27709
8888255249
MDR Report Key6689085
MDR Text Key79143388
Report Number1020379-2017-00050
Device Sequence Number1
Product Code EFT
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Type of Report Initial,Followup
Report Date 06/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Initial Date Manufacturer Received 06/15/2017
Initial Date FDA Received07/06/2017
Supplement Dates Manufacturer Received07/06/2017
Supplement Dates FDA Received07/13/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age15 MO
-
-